SCHEMBL733140

SCHEMBL733140

Cn1nc(-c2ccccc2)c2c[c]sc21

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.50
ALDH1A1 P00352 4/20 0.50
L3MBTL1 Q9Y468 1/20 0.43
MAPT P10636 3/20 0.42
HPGD P15428 3/20 0.42
POLB P06746 3/20 0.42
CYP1A2 P05177 2/20 0.42
CYP3A4 P08684 2/20 0.42
CYP2C9 P11712 2/20 0.42
CYP2C19 P33261 2/20 0.42
KHK P50053 1/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
MAPK1 P28482 2/20 0.40
HSD17B10 Q99714 2/20 0.40
CASP1 P29466 1/20 0.40
BRCA1 P38398 1/20 0.40
HTT P42858 1/20 0.40
CASP7 P55210 1/20 0.40
KEAP1 Q14145 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL733040 0.79 MAPT (0.45) KDM4EALDH1A1MAPTPOLBMEN1
SCHEMBL731118 0.74 L3MBTL1 (0.45) KDM4EALDH1A1L3MBTL1MAPTHPGD
SCHEMBL18500601 0.73 KDM4E (0.52) KDM4EALDH1A1L3MBTL1MAPTHPGD
SCHEMBL822675 0.72 L3MBTL1 (0.56) KDM4EALDH1A1L3MBTL1MAPTHPGD
SCHEMBL313577 0.72 ADORA2A (0.45) KDRCSNK1A1CDK8GSK3AGSK3B
SCHEMBL730566 0.71 L3MBTL1 (0.46) KDM4EALDH1A1L3MBTL1MAPTHPGD
SCHEMBL694855 0.71 L3MBTL1 (0.49) KDM4EALDH1A1L3MBTL1MAPTHPGD
SCHEMBL8317476 0.71 KDM4E (0.65) KDM4EALDH1A1L3MBTL1MAPTHPGD
SCHEMBL5924655 0.70 NPC1 (0.43) KDM4EALDH1A1L3MBTL1MAPTHPGD
SCHEMBL348602 0.67 KDM4E (1.00) KDM4EALDH1A1L3MBTL1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2120569-B1 SPIROCHROMANON DERIVATIVES MERCK SHARP & DOHME (US) 2013-08-14 EP disclosed
US-8138197-B2 Spirochromanon derivatives MSD K.K. (JP) 2012-03-20 US disclosed
EP-2120569-A2 SPIROCHROMANON DERIVATIVES Merck & Co., Inc. (US) 2009-11-25 EP disclosed
US-20090270436-A1 SPIROCHROMANON DERIVATIVES MERCK SHARP & DOHME LLC 2009-10-29 US disclosed
WO-2008088692-A2 SPIROCHROMANON DERIVATIVES MERCK & CO., INC. (US) 2008-07-24 WO disclosed
US-20060122184-A1 Cyanomethyl derivatives as cysteine protease inhibitors AXYS PHARMACEUTICALS, INC. (US) 2006-06-08 US disclosed
EP-1569954-A1 CYANOMETHYL DERIVATIVES AS CYSTEINE PROTEASE INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2005-09-07 EP disclosed
WO-2004052921-A1 CYANOMETHYL DERIVATIVES AS CYSTEINE PROTEASE INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2004-06-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090270436-A1 SPIROCHROMANON DERIVATIVES AKR1C3, CBR3, AKR1C4 KDM4E 3445/4885ALDH1A1 113/4885L3MBTL1 3118/4885
US-20060122184-A1 Cyanomethyl derivatives as cysteine protease inhibitors CTSF, CTSB, CTSK KDM4E 1572/4885ALDH1A1 3662/4885L3MBTL1 2160/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.